Whole Slide Imaging meets Laser Microdissection
MMI launch their latest solution at the AACR meeting in Chicago: CellScan
MMI launch their latest solution at the AACR meeting in Chicago: CellScan
Team heading to Chicago, USA, to interview scientists at the forefront of cancer research and report on the newest technologies
Dr. Adam Case monitors how T cells isolated from a mouse model of post-traumatic stress disorder kill pathogens in real time
Attend Miltenyi Biotec’s symposium to learn how researchers are tackling tumor heterogeneity with single-cell-analysis
Waters to showcase the technology advancing cancer research at AACR 2018
Photonex is preparing their exciting April conference at University College London
Learn how to get the most from your scratch wound healing assays
To be in with a chance of winning a $500/£400/450€ Amazon voucher, just tell us which new product, instrument or consumable made the most difference to your lab in 2017
Sign up now for this free webinar where you’ll learn an alternative to an otherwise laborious and time-consuming protocol
MilliporeSigma has developed a streamlined system that optimizes the critical steps of preparing cells and media
In this editorial feature, we bring you the latest developments in gene editing and CRISPR technology
Prof. Josephine Bunch, Agilent, MilliporeSigma and Bruker among those recognized at SelectSciences special 20th Anniversary Party
Dr. Jaroslav Fulneček, CEITEC MU, tells SelectScience about a new high-throughput assay for analysis of DNA-protein interactions
Read this exclusive interview with Louise Kenny, one of the founding directors of the INFANT Centre, to discover how they are using mass spectrometry to research preeclampsia and pre-term birth
Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute
Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix
Get the most from your wound healing assays with our free webinar: February 27, 2018 at 15:00 GMT / 16:00 CET / 10:00 EST / 07:00 PST
Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease